Charles C.
- Country
- France
- Department
- SMIT
Research Overview
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- Temocillin Non-Inferiority Trial Versus Ceftriaxone for Neisseria gonorrhoeae Infections in Adults
- Efficacy of 7-Day Oral Doxycycline for Asymptomatic Anal Lymphogranuloma Venereum Infection: Multicentre Study
Data & Insights
Has run more than one trial at 51 of 154 partner sites.
Specializations
HIV Treatment Innovation
The investigator specializes in evaluating novel therapeutic approaches for Human Immunodeficiency Virus (HIV-1) treatment, with particular focus on comparing antiretroviral regimens and optimizing drug combinations for treatment-naïve patients.
- Doravirine-based therapies
- Two-drug versus three-drug regimens
- Viral load management strategies
Infectious Disease Management
Active research in treating various infectious conditions, including bartonellosis, pneumococcal infections, and syphilis, with emphasis on innovative treatment approaches and vaccine studies.
- Cat scratch disease interventions
- Pneumococcal vaccination strategies
- Alternative antibiotic protocols
Emerging Viral Diseases
Focuses on prevention and treatment of viral infections including Human Papillomavirus (HPV) and Monkeypox (Mpox), investigating vaccine efficacy and therapeutic interventions.
- External genital warts management
- Vaccine administration techniques
- Community-acquired pneumonia protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.